This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
MONDAY, Feb. 10, 2025 -- Twin pregnancies have increased risks for cardiovascul...
MONDAY, Feb. 10, 2025 -- Among cancer survivors, pain is associated with an inc...
MONDAY, Feb. 10, 2025 -- Emergency department opioid prescriptions are associat...
The FDA warning highlights ongoing anxiety over quality control among pharmaceut...
The drug is cleared to treat complicated intra-abdominal infections, including t...
Shares in the brain drug developer rose by more than 20% Monday on news of the d...
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab...
Novartis opened the doors to a €40 million ($41.2 million) viral vector facility...
According to the agency, BD has reported 30 serious injuries and four deaths lin...
A new initiative rolled out under President Donald Trump’s administration is cut...
Merck KGaA is said to be in advanced talks to acquire cancer and are disease spe...
Shares of Axsome Therapeutics jumped by more than 20% after the company resolved...
Applications for new human medicines under evaluation: February 2025
With Globus paying $5.85 for each of Nevro’s outstanding shares, that amounts to...
Boehringer Ingelheim has cemented the potential of its idiopathic pulmonary fibr...
Pharmacovigilance Risk Assessment Committee (PRAC): 10 - 13 February 2025, Europ...
Agenda of the PRAC meeting 10-13 February 2025
This week in health care business news: Rising costs hit health insurers, United...
Human medicines European public assessment report (EPAR): Ituxredi, rituximab, D...
In what one analyst called a “unique situation,” the company stopped dosing pati...
CEO Hervé Affagard discusses MaaT Pharma's new approach to microbiome-driven th...
Experts from Wilco Source and CitiusTech discuss how AWS and Salesforce’s indust...
Andrea Bortolato of $5.6 billion startup SandboxAQ on the opportunity to transfo...